Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06707090 · ClinicalTrials.gov registry record · Phase 3
Tissue Repair Gel in Venous Leg Ulcers (US)
A Phase 3 study of Venous Leg Ulcer and Wound Heal, sponsored by TR Therapeutics.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 312
- Enrollment target
- 20
- Study locations
NCT06707090: Recruiting Phase 3 study of Venous Leg Ulcer and Wound Heal, sponsored by TR Therapeutics.
NCT06707090 is a Phase 3 study of Venous Leg Ulcer and Wound Heal that is actively recruiting participants, run by TR Therapeutics. The registered enrollment target is 312 participants, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06707090, a Phase 3 study of Venous Leg Ulcer and Wound Heal, is actively recruiting participants, sponsored by TR Therapeutics.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 312 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Primary Outcome
Patient count
Conditions Studied
Interventions
- OTHER Standard of care
- DRUG TR987 0.1% gel + Standard of Care
Study Locations (20)
Florida
- Clincial Research Site 47 - Deerfield Beach
- Clincial Research Site 38 - Hollywood
- Clincial Research Site 40 - Jacksonville
- Clincial Research Site 19 - Miami
- Clincial Research Site 26 - Miami
- Clincial Research Site 13 - Pembrook Pines
- Clincial Research Site 51 - Tamarac
California
- Clincial Research Site 43C - Castro Valley
- Clincial Research Site 14 - Fresno
- Clincial Research Site 11 - Los Angeles
- Clincial Research Site 43A - San Francisco
- Clincial Research Site 43B - San Francisco
- Clincial Research Site 54 - Vista
Illinois
- Clincial Research Site 22 - Chicago
- Clincial Research Site 34 - Chicago
- Clincial Research Site 10 - O'Fallon
- Clincial Research Site 49 - Springfield
Louisiana
- Clincial Research Site 04 - Bossier City
- Clincial Research Site 01 - Lafayette
Arizona
- Clincial Research Site 21 - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2025-01-28 |
| Est. Completion | 2028-02 |
| Phase | Phase 3 |
What NCT06707090 shows while recruiting
NCT06707090 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher).
The record links to 8 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT06707090 names 20 study sites across 5 states, led by Florida, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT06707090 about?
NCT06707090 is a clinical study titled "Tissue Repair Gel in Venous Leg Ulcers (US)". The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
What is the current status of trial NCT06707090?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2025-01-28. Estimated completion is 2028-02.
What conditions does trial NCT06707090 study?
This clinical trial studies the following conditions: Venous Leg Ulcer, Wound Heal, Venous Ulcer, Wounds, Venous Stasis.
What interventions are being tested in trial NCT06707090?
The interventions under investigation include: Standard of care (OTHER), TR987 0.1% gel + Standard of Care (DRUG).
Who is sponsoring clinical trial NCT06707090?
This trial is sponsored by TR Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06707090 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06707090's enrollment target sits among peer trials
312 7th of 35 higher than 28 of 35 other Venous Leg Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
ACTIVE NOT RECRUITING · Phase 3
-
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
COMPLETED · Phase 3
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI